Research Awards Listing
Research follows dollars, and The Lustgarten Foundation believes that increasing funds for pancreatic cancer research will translate into enhanced patient care, and ultimately, a cure.
The Lustgarten Foundation firmly believes that increasing funds for pancreatic cancer research is the surest path to improved patient care and eventually, to a cure. To date, we have committed more than $120 million to providing the best and brightest minds with the resources to pursue the study and eradication of the disease.
View Award Listings by Year
2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000-1998
2015 Research Grants
Daniel Von Hoff, M.D., FACP
Ronald Evans, Ph.D.
Gerard Evan, Ph.D.
SU2C/CRUK/The Lustgarten Foundation Pancreatic Cancer Dream Team: Reprogramming of Transcriptional Circuitry to Control Pancreatic Cancer Translational Genomics Research Institute (TGen) Salk Institute University of Cambridge
Jeffrey Drebin, M.D., Ph.D.
Curtis Callan, Ph.D.
David Ting, M.D.
Liberating T-Cell Mediated Immunity of Pancreatic Cancer SU2C Convergence Team Translational Research Grant University of Pennsylvania Princeton University Massachusetts General Hospital
Brian Wolpin, M.D.
Clinical Science Coalition
Dana-Farber Cancer Institute
Matthew Vander Heiden, M.D., Ph.D.
Research Investigator Award Understanding the metabolic interplay between tumor and host in pancreatic cancer Massachusetts Institute of Technology
Bert Vogelstein, M.D.
MSI Research Study Johns Hopkins University
“As a result of Lustgarten Foundation funding, we were able to produce enough vaccine to test our potential therapy in pancreatic cancer patients. Without this funding, we would not have been able to conduct this trial.”
- Elizabeth Jaffee, M.D., Johns Hopkins Medical Institutions